Lupin Limited Share Price & Analysis

Lupin partners with ERN to launch Luforbec® in Spain

*Lupin partners with ERN to launch Luforbec® in Spain*. Lupin Limited has announced a collaboration with ERN to launch Luforbec® (beclometasone/formoterol) pMDI in Spain. The product is indicated for asthma and COPD management. This marks Lupin’s strategic expansion into the European respiratory market. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Pharma

Lupin announces AGM and e-voting details

Lupin has released newspaper publication details for its upcoming Annual General Meeting and e-voting process. The filing informs shareholders about participation procedures and key deadlines. **No financial impact** is expected from this routine disclosure. It's a standard compliance requirement ahead of the AGM. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

Lupin named among India's best employers

*Lupin named among India's best employers* Lupin has been recognized in the 'Nation-Builders' category by Great Place To Work® India 2026. The award highlights its workplace culture and employee engagement. While positive for brand image, it has minimal financial impact. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG

Lupin named among world's most sustainable companies by TIME

*Lupin named among world's most sustainable companies by TIME and Statima.* Lupin has been recognized as one of the **World's Most Sustainable Companies** by TIME and Statista. The acknowledgment highlights the company's **ESG initiatives** and sustainability performance globally. While positive for reputation, it does not imply immediate financial impact. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG

Lupin gets FDA nod for prostate cancer drug

*Lupin gets FDA nod for prostate cancer drug* — Lupin has received tentative approval from the USFDA for its prostate cancer treatment drug. The approval allows Lupin to launch the drug upon patent expiry or settlement. This move strengthens its oncology portfolio in the key US market. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #pharma

NATCO Pharma, Lupin get USFDA approval for cancer drug

*NATCO Pharma, Lupin get USFDA approval for Eribulin Mesylate injection.* This greenlight allows both firms to launch a generic version of the cancer drug in the US market. The approval is expected to drive near-term revenue via market exclusivity. 📊 *STOCKS:* NATCOPHARM, LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #USFDA

Lupin's Ankleshwar plant gets US FDA EIR

*Lupin's Ankleshwar facility has received an Establishment Inspection Report (EIR) from the US FDA.* The EIR follows a recent regulatory inspection and indicates findings are under review. **No observations of significance** were reported, signaling possible clearance. This paves way for resuming or expanding US drug shipments. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #USFDA

Lupin gets FDA nod for famotidine injection.

*Lupin gets FDA nod for famotidine injection.* The company received U.S. FDA approval for its generic famotidine injection, USP, strengthening its hospital products portfolio. This approval allows Lupin to launch the injectable anti-ulcer drug in the U.S. market. The product had **$**120 million** in annual sales** in the U.S. over the past 12 months. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #FDAApproval

Lupin gets U.S. FDA nod for new drug

*Lupin gets U.S. FDA nod for new drug.* The company has received approval for Glycerol Phenylbutyrate Oral Liquid, used in urea cycle disorder treatment. This expands Lupin’s presence in the U.S. specialty market. The drug had **$28 million** in U.S. sales over the past year. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #FDAApproval

Lupin receives EIR from US FDA for Goa facility

*Lupin receives EIR from US FDA for its Goa facility.* The **EIR (Establishment Inspection Report)** signifies successful completion of FDA inspection at the facility, validating manufacturing practices and quality standards. This regulatory clearance strengthens Lupin's operational credibility in the US market and supports continued product registrations from this site. 📊 *STOCKS:* LUPIN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #FDA